Standardizing Real World Data in Rare Disease: ATHN’s Journey Blog Post
Learn how Certara helped ATHN standardize Real World Data for regulatory submissions, advancing rare disease research with compliant, actionable insights.
Registration Confirmation Page
Registration confirmation Confirmed Thank you for pre-registering, we will notify you once the date is confirmed. You May Also Like AllCertara Products - Phoenix Latest Phoenix PK/PD analysis & modeling...
Mechanistic Modeling to Meet Challenges in ADC Development Blog Post
Kimiko McGirr, PhD Scott Gruver Diana Marcantonio, PhD 2025 年 4 月 4 日 Navigating the challenges in antibody-drug conjugates (ADCs) development requires overcoming complex hurdles in through the entire development process. ADC ...
A Quick Guide to SDTM Dataset Creation APAC PA Page
GUIDEA Quick Guide to SDTM Dataset Creation Our quick guide can help you create your SDTM datasets faster and easier. What you’ll learn The basics of SDTM dataset creation, including...
To Generate or Not? Where GPTs Are Most Valuable Across Your CSR APAC PA Page
WEBINARTo Generate or Not? Where GPTs Are Most Valuable Across Your CSR Effectiveness of generative AI comes down to data and prompting. 在写作环境中实施生成式人工智能的一个常见误区，是对 LLMs 如何解释提示和分析所接触到的数据的误...
Streamline Regulatory Writing with AI-Powered Solutions APAC PA Page
WHITE PAPERStreamline Regulatory Writing with AI-Powered Solutions Accelerate the preparation & submission of crucial regulatory documents The demands of pharmaceutical regulatory writing can be overwhelming with countless hours spent on...
Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis Blog Post
演讲嘉宾：Pratap Singh, PhD Clinical Pharmacology Leader, Ionis Pharmaceuticals Pratap Singh, Ph.D., is currently an Executive Director and Franchise head within the Clinical pharmacology department at Ionis Pharmaceuticals, a company...
